113 related articles for article (PubMed ID: 11795688)
1. Changes in symptoms, lipid and hormone levels after the administration of a cream with phytoestrogens in the Climacteric--preliminary report.
Carranza-Lira S; Barahona OF; Ramos D; Herrera J; Olivares-Segura A; Cardoso G; Posadas-Romero C
Int J Fertil Womens Med; 2001; 46(6):296-9. PubMed ID: 11795688
[TBL] [Abstract][Full Text] [Related]
2. [Possibilities for an individualized approach to the treatment of climacteric symptoms with phytoestrogens].
Kolarov G; Nalbanski B; Kamenov Z; Orbetsova M; Georgiev S; Nikolov A; Marinov B
Akush Ginekol (Sofiia); 2001; 40(4):18-21. PubMed ID: 11803864
[TBL] [Abstract][Full Text] [Related]
3. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women.
Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392
[TBL] [Abstract][Full Text] [Related]
4. Low and ultra low-dose estrogen therapy for climacteric symptom control--preliminary report.
Carranza-Lira S; Gooch AL; Velasco-Díaz G; Solano J; Arzola-Paniagua A
Int J Fertil Womens Med; 2006; 51(4):171-5. PubMed ID: 17184102
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City.
Carranza-Lira S; Velasco Díaz G; Olivares A; Chán Verdugo R; Herrera J
Int J Fertil Womens Med; 2006; 51(2):83-8. PubMed ID: 16881384
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
[TBL] [Abstract][Full Text] [Related]
7. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy.
Petri Nahas E; Nahás Neto J; De Luca L; Traiman P; Pontes A; Dalben I
Maturitas; 2004 Aug; 48(4):372-80. PubMed ID: 15283929
[TBL] [Abstract][Full Text] [Related]
8. A randomized isoflavone intervention among premenopausal women.
Maskarinec G; Williams AE; Inouye JS; Stanczyk FZ; Franke AA
Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):195-201. PubMed ID: 11867507
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
10. Isoflavone treatment for acute menopausal symptoms.
Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
Ho SC; Chen YM; Ho SS; Woo JL
Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
[TBL] [Abstract][Full Text] [Related]
12. Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin.
Shoff SM; Newcomb PA; Mares-Perlman JA; Klein BE; Haffner SM; Storer BE; Klein R
Nutr Cancer; 1998; 30(3):207-12. PubMed ID: 9631492
[TBL] [Abstract][Full Text] [Related]
13. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients.
Nikander E; Kilkkinen A; Metsä-Heikkilä M; Adlercreutz H; Pietinen P; Tiitinen A; Ylikorkala O
Obstet Gynecol; 2003 Jun; 101(6):1213-20. PubMed ID: 12798527
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial.
Sammartino A; Tommaselli GA; Gargano V; di Carlo C; Attianese W; Nappi C
Gynecol Endocrinol; 2006 Nov; 22(11):646-50. PubMed ID: 17145651
[TBL] [Abstract][Full Text] [Related]
15. The clinical use of a preparation based on phyto-oestrogens in the treatment of menopausal disorders.
Russo R; Corosu R
Acta Biomed; 2003 Dec; 74(3):137-43. PubMed ID: 15055018
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.
Kaari C; Haidar MA; Júnior JM; Nunes MG; Quadros LG; Kemp C; Stavale JN; Baracat EC
Maturitas; 2006 Jan; 53(1):49-58. PubMed ID: 16257151
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2004 Jan; 87(1):33-40. PubMed ID: 14971532
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.
Benster B; Carey A; Wadsworth F; Vashisht A; Domoney C; Studd J
Menopause Int; 2009 Jun; 15(2):63-9. PubMed ID: 19465671
[TBL] [Abstract][Full Text] [Related]
19. Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.
Carranza-Lira S; Gooch AL; Saldivar N; Osterwalder MS
Int J Fertil Womens Med; 2007; 52(2-3):93-6. PubMed ID: 18320867
[TBL] [Abstract][Full Text] [Related]
20. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.
Unfer V; Casini ML; Costabile L; Mignosa M; Gerli S; Di Renzo GC
Fertil Steril; 2004 Jul; 82(1):145-8, quiz 265. PubMed ID: 15237003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
